Roche Molecular Systems Director of Operations Salaries in Wilmington, DE
The average Roche Molecular Systems Director of Operations in Wilmington, DE earns an estimated $178,835 annually, which includes an estimated base salary of $149,109 with a $29,726 bonus. Roche Molecular Systems' Director of Operations compensation is $38,069 more than the US average for a Director of Operations. Director of Operations salaries at Roche Molecular Systems in Wilmington, DE can range from $62,000 - $340,000.
In Wilmington, DE, The Operations Department at Roche Molecular Systems earns $3,240 more on average than the Business Development Department.
Last updated 2 years ago.
- $149,109
- avg. base
- $29,726
- avg. bonus
Director of Operations Salaries at Roche Molecular Systems
In Wilmington, DE, Directors of Operations earn $3,571 more than Directors of Operations.
Compensation at Roche Molecular Systems by Department
In Wilmington, DE, The Operations Department averages $3,240 more than the Business Development Department, and $10,234 less than the Customer Support Department
Director of Operations Compensation by Gender (All Companies)
The average female Director of Operations at companies similar size to Roche Molecular Systems reported making $178,169, while the average male Director of Operations at similar sized companies reported making $182,882.
Director of Operations Compensation by Ethnicity (All Companies)
The average Asian or Pacific Islander Director of Operations at companies similar size to Roche Molecular Systems reported making $184,403, while the average African American/Black Director of Operations at similar sized companies reported making $141,003.
How Directors of Operations at Roche Molecular Systems Rate Their Compensation
The majority of Directors of Operations at Roche Molecular Systems believe they're compensated fairly. 100% of Directors of Operations at Roche Molecular Systems say they receive annual bonuses, and the majority (60%) are satisfied with their benefits. See more compensation ratings at Roche Molecular Systems
